184 related articles for article (PubMed ID: 9138175)
1. Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study.
Hyams JS; Wyzga N; Kreutzer DL; Justinich CJ; Gronowicz GA
J Pediatr Gastroenterol Nutr; 1997 Mar; 24(3):289-95. PubMed ID: 9138175
[TBL] [Abstract][Full Text] [Related]
2. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
[TBL] [Abstract][Full Text] [Related]
3. Effect of Crohn's disease on bone metabolism in vitro: a role for interleukin-6.
Sylvester FA; Wyzga N; Hyams JS; Gronowicz GA
J Bone Miner Res; 2002 Apr; 17(4):695-702. PubMed ID: 11918227
[TBL] [Abstract][Full Text] [Related]
4. Altered bone metabolism in inflammatory bowel disease.
Bischoff SC; Herrmann A; Göke M; Manns MP; von zur Mühlen A; Brabant G
Am J Gastroenterol; 1997 Jul; 92(7):1157-63. PubMed ID: 9219790
[TBL] [Abstract][Full Text] [Related]
5. Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.
Reddy KP; Markowitz JE; Ruchelli ED; Baldassano RN; Brown KA
Dig Dis Sci; 2007 Feb; 52(2):365-72. PubMed ID: 17219072
[TBL] [Abstract][Full Text] [Related]
6. [Serum bone marker measurements in bone metabolism disorders associated with inflammatory bowel diseases].
Miheller P; Tóth M; Molnár E; Zágoni T; Rácz K; Tulassay Z
Orv Hetil; 2001 Jul; 142(29):1557-60. PubMed ID: 11494747
[TBL] [Abstract][Full Text] [Related]
7. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
[TBL] [Abstract][Full Text] [Related]
8. Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis.
Gilman J; Shanahan F; Cashman KD
Aliment Pharmacol Ther; 2006 Apr; 23(7):1007-16. PubMed ID: 16573803
[TBL] [Abstract][Full Text] [Related]
9. Hair Mineral and Trace Element Contents as Reliable Markers of Nutritional Status Compared to Serum Levels of These Elements in Children Newly Diagnosed with Inflammatory Bowel Disease.
Cho JM; Yang HR
Biol Trace Elem Res; 2018 Sep; 185(1):20-29. PubMed ID: 29282618
[TBL] [Abstract][Full Text] [Related]
10. Detectable Laboratory Abnormality Is Present up to 12 Months Prior to Diagnosis in Patients with Crohn's Disease.
Irwin JR; Ferguson E; Simms LA; Hanigan K; Doecke JD; Langguth D; Arnott A; Radford-Smith G
Dig Dis Sci; 2019 Feb; 64(2):503-517. PubMed ID: 30478769
[TBL] [Abstract][Full Text] [Related]
11. An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
Sugimoto K; Ikeya K; Iida T; Kawasaki S; Arai O; Umehara K; Watanabe F; Tani S; Oishi S; Osawa S; Yamamoto T; Hanai H
Dig Dis Sci; 2016 Jan; 61(1):99-106. PubMed ID: 26254083
[TBL] [Abstract][Full Text] [Related]
12. Serum nitrate levels in ulcerative colitis and Crohn's disease.
Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
Tan B; Li P; Lv H; Li Y; Wang O; Xing XP; Qian JM
J Dig Dis; 2014 Mar; 15(3):116-23. PubMed ID: 24354597
[TBL] [Abstract][Full Text] [Related]
14. Characterization of circulating interleukin-1 receptor antagonist expression in children with inflammatory bowel disease.
Hyams JS; Fitzgerald JE; Wyzga N; Treem WR; Justinich CJ; Kreutzer DL
Dig Dis Sci; 1994 Sep; 39(9):1893-9. PubMed ID: 8082495
[TBL] [Abstract][Full Text] [Related]
15. Relationships between serum IGF-1, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease.
Street ME; de'Angelis G; Camacho-Hübner C; Giovannelli G; Ziveri MA; Bacchini PL; Bernasconi S; Sansebastiano G; Savage MO
Horm Res; 2004; 61(4):159-64. PubMed ID: 14691340
[TBL] [Abstract][Full Text] [Related]
16. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
17. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
Zhang W; Teng G; Wu T; Tian Y; Wang H
Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078
[TBL] [Abstract][Full Text] [Related]
18. Systemic Molecular Mediators of Inflammation Differentiate Between Crohn's Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in Therapy.
Kiernan MG; Coffey JC; Sahebally SM; Tibbitts P; Lyons EM; O'leary E; Owolabi F; Dunne CP
J Crohns Colitis; 2020 Jan; 14(1):118-129. PubMed ID: 31241755
[TBL] [Abstract][Full Text] [Related]
19. The serum concentrations of zinc, copper and selenium in children with inflammatory bowel disease.
Ojuawo A; Keith L
Cent Afr J Med; 2002; 48(9-10):116-9. PubMed ID: 14562534
[TBL] [Abstract][Full Text] [Related]
20. Increased serum bone sialoprotein concentrations in patients with Crohn's disease.
Faust D; Menge F; Armbruster FP; Lembcke B; Stein J
Z Gastroenterol; 2003 Mar; 41(3):243-7. PubMed ID: 12664344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
